BeOne Medicines
ONC
#542
Rank
C$65.59 B
Marketcap
C$574.23
Share price
5.09%
Change (1 day)
24.30%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): C-$22.56

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$8.44. In 2022 the company made an earnings per share (EPS) of C-$27.33 a decrease over its 2021 EPS that were of C-$21.46.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$22.56-17.47%
2022C-$27.3327.35%
2021C-$21.46-19.96%
2020C-$26.8120.81%
2019C-$22.2031.52%
2018C-$16.88417.57%
2017C-$3.26-37.16%
2016C-$5.19158.95%
2015C-$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.34-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA